Dr. Akram Almakki

Nephrologist. Adjunct Clinical Associate Professor of Medicine at IUSM-WL and Director of GME at IU Health Arnett. Work at IU Health Arnett. Practice Website – http://iuhealth.org/arnett/nephrology/ Affiliate Faculty of Pharmacy Practice (College of Pharmacy ). Purdue University: West Lafayette, IN, US. 2011 to present. (Invited position) Fellow of American Society of Nephrology (FASN) since 2004 Fellow of American College of Physicians (FACP) awarded in 2001 and inducted in 2002 Clinical Research Experience: • Principal Investigator in a study with Purdue University’s College of Pharmacy: Ergocalciferol versus cholecalciferol. • Principal Investigator of the CentrosFLO Trial • Member of Clinical Research Oversight Committee at Indiana University Health Arnett • Principal Investigator in: Principal Investigator in: AZEPTIC Trial for Zuragen • Principal Investigator in: Affymax (AFX01-11) Trial (PEARL Study) • Sub-Investigator in AMGEN’s Cinacalcet in CKD study Employment: Indiana University Health Arnett Hospital: Lafayette, IN, US. 2004 to present | Nephrologist since 2004. Director of GME since 2012 (Nephrology) Monticello Medical Center: Monticello, Indiana, US. 1998 to 2004 | Internist. Director of Internal Medicine (Internal Medicine) Education and qualifications: American Board of Internal Medicine: Philadelphia, PA, US. 1998 to present | Board Certified in Nephrology (Nephrology) American Board of Internal Medicine: Philadelphia, PA, US. 1996 to present | Board Certified in Internal Medicine (Internal Medicine) Wayne State University: Detroit, MI, US. 1996-07-01 to 1998-06-30 | Nephrology Fellow. Chief Nephrology Felow from 1997-1998 (Nephrology) MedStar Harbor Hospital: Baltimore, Maryland, US. 1993-07-01 to 1996-06-30 | Internal Medicine Resident (Internal Medicine) Damascus University Faculty of Medicine: Damascus, Damascus Governorate, SY. 1986 to 1992 | M.D. (School of Medicine)

Board certifications